Title : Lymphatic–cardiovascular interactions in global health: Non-invasive lymphatic modulation, infectious disease burden, and cardiometabolic outcomes in low-resource and disaster-prone settings
Abstract:
The lymphatic system is a fundamental yet underrecognized component of cardiovascular regulation, immune homeostasis, and metabolic balance. Lymphatic dysfunction contributes to chronic inflammation, endothelial impairment, venous hypertension, and interstitial fluid overload, thereby accelerating cardiometabolic disease progression. These interactions are particularly pronounced in low-resource and disaster-prone settings, where infectious diseases and healthcare inequities exacerbate vascular morbidity.
This presentation aims to define the mechanistic and clinical relevance of lymphatic–cardiovascular interactions and to evaluate non-invasive lymphatic modulation as an adjunctive strategy for cardiovascular risk reduction in populations affected by infectious disease burden and limited healthcare access.
A translational and integrative approach was employed, combining clinical investigations of intermittent pneumatic compression and multi-chamber peristaltic lymphatic drainage systems with mechanistic assessments of lymphatic flow dynamics, inflammatory biomarker modulation, microvascular perfusion, and venous return. Epidemiological and public health data from tropical and underserved regions were incorporated to assess the impact of neglected tropical diseases, immunization strategies, disaster-related healthcare disruption, and environmental determinants on cardiometabolic outcomes.
Non-invasive lymphatic modulation demonstrated consistent improvements in lymphatic transport efficiency, reduction of peripheral edema, and attenuation of chronic inflammatory signaling. These effects correlated with enhanced endothelial function, improved venous hemodynamics, and favorable cardiometabolic markers. In populations affected by lymphatic filariasis, malaria, and related tropical infections, chronic lymphatic injury was associated with sustained vascular dysfunction and increased cardiovascular vulnerability, particularly under environmental stress.
These findings underscore a clinically meaningful lymphatic–cardiovascular axis and support the integration of scalable, non-invasive lymphatic therapies into global cardiovascular prevention strategies.
Keywords: Lymphatic–cardiovascular interactions; Non-invasive lymphatic modulation; Intermittent pneumatic compression; Lymphedema; Cardiometabolic risk; Endothelial dysfunction; Chronic inflammation; Tropical medicine; Neglected tropical diseases; Disaster medicine; Global health; Low-resource settings.
